Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks

Background: Barriers to accessing oral oncolytic therapy include insurance authorization, high copays and limited distribution drug (LDD) networks. In September 2015, a pharmacist joined an outpatient hematology clinic to facilitate timeliness of medications (for which the pharmacy has access) dispe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Drug Assess
Main Authors: Zuckerman, Autumn D., Peter, Megan E., Starks, Samuel, Maulis, Matthew, Declerq, Josh, Choi, Leena, Jagasia, Madan
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Poster #45
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764336/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658326
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares